Cost control saves the day for Medibank
The stock market heads into the final day of a busy week with a broadly neutral macro setting from international markets.
- {{x.value}}
{{ twilioFailed ? 'SMS Code Failed to Send…' : 'Enter your SMS code' }}
Please type the 5 digit verification code sent to {{user.DayPhone}}
We cannot send you a code via SMS to {{user.DayPhone}}
Verify your mobile number
{{ content.trialHeading.replace('{0}', user.FirstName) }}
Please enter your mobile number and press send to receive a text message with a verification code.
{{ content.upgradeHeading.replace('{0}', user.FirstName) }}
The email address you entered is registered with InvestSMART
Please login to continue
We have sent you an email with the details of your registration.
Already a member? Log in
Looks you are already a member. Please enter your password to proceed
{{ upgradeCTAText }}
Updating information
Please wait ...
Your membership to InvestSMART Group recently failed to renew.
Please make sure your payment details are up to date to continue your membership.
Having trouble renewing?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
You've recently updated your payment details.
It may take a few minutes to update your subscription details, during this time you will not be able to view locked content.
If you are still having trouble viewing content after 10 minutes, try logging out of your account and logging back in.
Still having trouble viewing content?
Please contact Member Services on support@investsmart.com.au or 1300 880 160
Please click on the ACTIVATE button to activate your Eureka Report 15-day free trial
Please click on the ACTIVATE button to activate your Intelligent Investor 15-day free trial
Please click on the ACTIVATE button to finalise your membership
Unsuccessful registration
Registration for this event is available only to Eureka Report members. View our membership page for more information.
Registration for this event is available only to Intelligent Investor members. View our membership page for more information.
- You are already registered for this event.
- This event is already full.
- Please select a quantity for at least one ticket.
- {{ i }}
Forgotten password
Please enter your email address below to request a new password
- Indepth analysis of ASX listed shares
- BUY, Hold and Sell Recommendations
- Ideas Lab
- Special Reports
- Alan Kohler’s Weekend Briefing
- Interviews with CEO’s & top influencers
- Money Cafe and Talking Finance
- Super Advice and Q&A with Ask Alan
The stock market heads into the final day of a busy week with a broadly neutral macro setting from international markets.
Market action suggests that investors are looking through the daily round of claim and counter claim on the Greek debt negotiations and are disinclined to take any action on this score until there are concrete developments.
The fact that oil prices rallied off their lows in the US trading session indicates that markets are now looking forward to production cuts in months to come. Oil traders are starting to look beyond ongoing production increases and the large build in inventory levels that’s occurring at the moment. This sentiment is also likely to see local energy stocks hold relatively steady today despite last night’s news of a sharp rise in US crude inventories.
Today’s trading is again likely to be dominated by reaction to profit results. Investors in Medibank are likely to be relatively satisfied by today’s result. There may be room for a little nervousness in slightly softer than expected premium revenue and management outlook comments pointing to the continuing challenges posed by affordability for customers. On the other hand investors are likely to be pleased by Medibank’s progress on cost cutting. For many this is the core rationale for owning the stock. The question for Medibank shareholders today will be whether today’s result justifies the extent of recent gains in the stock price.
For further comment from Ric Spooner please call 02 8221 2137.